New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
10:00 EDTORBT, WETF, RCL, RGDX, WFT, PACW, OAS, ICFI, HUBG, BAP, CSCOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Cisco (CSCO) upgraded to Outperform from Sector Perform at Pacific Crest... Credicorp (BAP) upgraded to Neutral from Underweight at HSBC... Hub Group (HUBG) upgraded to Outperform from Neutral at RW Baird... ICF International (ICFI) upgraded to Buy from Neutral at SunTrust... Oasis Petroleum (OAS) upgraded to Buy from Neutral at SunTrust... PacWest Bancorp (PACW) upgraded to Buy from Hold at Wunderlich... Weatherford (WFT) upgraded to Hold from Underperform at Jefferies... Response Genetics (RGDX) upgraded to Buy from Neutral at Ladenburg... Royal Caribbean (RCL) upgraded to Buy from Hold at Argus... Wisdom Tree (WETF) upgraded to Buy from Hold at Gabelli... Orbit International (ORBT) upgraded to Buy from Hold at C.K. Cooper.
News For CSCO;BAP;HUBG;ICFI;OAS;PACW;WFT;RGDX;RCL;WETF;ORBT From The Last 14 Days
Check below for free stories on CSCO;BAP;HUBG;ICFI;OAS;PACW;WFT;RGDX;RCL;WETF;ORBT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 19, 2014
11:05 EDTCSCOImperva seen as takeover candidate under new CEO
Subscribe for More Information
08:42 EDTCSCOImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.
August 18, 2014
13:19 EDTRGDXResponse Genetics to serve as molecular screening center for ALCHEMIST
Response Genetics (RGDX) announced that it has been awarded a multi-million dollar research subcontract to support the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST. ALCHEMIST consists of 3 integrated precision medicine trials that are being implemented through the National Clinical Trials Network of the National Cancer Institute, or NCI, a screening trial and two associated treatment trials. The research subcontract was awarded by Leidos Biomedical Research (LDOS).
10:01 EDTWETFOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Hold at Deutsche Bank... CNOOC (CEO) upgraded to Neutral from Underperform at Credit Suisse... Dollar General (DG) upgraded to Buy from Neutral at Sterne Agee... Equity Residential (EQR) upgraded to Hold from Underperform at Jefferies... HMS Holdings (HMSY) upgraded to Overweight from Equal Weight at First Analysis... HP (HPQ) upgraded to Buy from Neutral at Monness Crespi... Halcon Resources (HK) upgraded to Buy from Hold at MLV & Co.... KapStone (KS) upgraded to Buy from Hold at Deutsche Bank... Sportsman's Warehouse (SPWH) upgraded at RW Baird... Westlake Chemical (WLK) upgraded to Neutral from Reduce at SunTrust... WisdomTree (WETF) upgraded to Neutral from Sell at Citigroup... Zimmer (ZMH) upgraded to Outperform from Market Perform at William Blair.
06:14 EDTWETFWisdomTree upgraded to Neutral from Sell at Citigroup
Subscribe for More Information
August 15, 2014
17:02 EDTCSCOStocks end week slightly higher despite flare-up in Russian tensions
Subscribe for More Information
August 14, 2014
17:41 EDTWFTPoint72 Asset Management gives quarterly update on stakes
Subscribe for More Information
17:27 EDTWFTAppaloosa gives quarterly update on stakes
Subscribe for More Information
16:30 EDTCSCOOn The Fly: Closing Wrap
Subscribe for More Information
12:31 EDTCSCOCisco shares trade lower as company announces 6,000 job cuts
Subscribe for More Information
12:30 EDTCSCOOn The Fly: Midday Wrap
Subscribe for More Information
09:36 EDTCSCOActive equity options trading on open
Subscribe for More Information
07:47 EDTCSCOCisco price target raised to $33 from $30 at Cowen
Subscribe for More Information
07:34 EDTCSCOCisco price target raised to $29 from $26.50 at UBS
UBS raised its price target on Cisco to $29 from $26.50 following its Q4 results. The firm sees continued momentum in several markets and products and strong cash flow and keeps its Buy rating on Cisco shares.
07:16 EDTRGDXResponse Genetics expects FY14 to be 'transformational year'
The company said, "We expect FY14 could be a transformational year for our company in many respects, not the least of which is we expect both ResponseDX unit volumes and revenue to continue to increase as a result of the initiatives and infrastructure that we implemented over the last two years, including our TC/PC program, our recently acquired and launched ResponseDX: Tissue of OriginTM test, the introduction of several new tests and our where-with-all to provide unique testing services resulting from our patient-centric, multiple technology approach for providing pathologists and oncologists with testing options that they deem best suited for each of their patients based on individual patient needs. With these offerings in place, and our emphasis on execution, we believe we have strengthened our position as a content driven, solid tumor, molecular diagnostics company with a differentiated approach for today's rapidly changing and increasing cost conscious healthcare environment."
07:09 EDTRGDXResponse Genetics reports Q2 EPS (8c) vs. (4c) last year
Subscribe for More Information
06:23 EDTCSCOCisco multiple prices in growth potential, says Citigroup
Subscribe for More Information
05:56 EDTCSCOCisco earnings outlook could prove conservative, says Wells Fargo
Subscribe for More Information
05:52 EDTCSCOOpco sees Cicso results as favorable for supply chain
Subscribe for More Information
05:39 EDTCSCOCisco shares have little downside risk, says Piper Jaffray
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use